Wockhardt, one of the largest generic pharmaceutical companies in the UK.

Welcome to Wockhardt UK

Wockhardt UK is one of the largest generic pharmaceutical companies in the UK and we pride ourselves on our long established heritage. Over the years we have been known as Weddel, CP Pharmaceuticals and finally Wockhardt in 2003, becoming Wockhardt UK in 2004. Since the acquisition of CP Pharmaceuticals, annual UK turnover continues to grow and we now have a UK workforce of over 350 employees.

What we do

We specialise in the manufacture and supply of generic medicines, with a growing portfolio of over 250 products lines. We work hard to support the needs of our customers:

A leading supplier to the Hospital and Retail Pharmacy sectors
Manufacture of own label products for Supermarkets, Multiple Retailer, Pharmacy Chain and Wholesaler customers
Growing footprint with International customers
Contract manufacturing for clients, utilising more than 25 years of experience

Our vision, mission & values

Our Vision is to be the most admired Healthcare Group from India.

We believe that people are the mainstay of our organisation and it is our mission to offer an enriching environment for professional and personal growth for every employee, with an open, participative culture that permeates each level of the organisation. Investing in people means that we can always be confident that the needs of our customers are met.

For further information about Wockhardt's full shared mission and vision, please click here.

Our UK Location

Our Wrexham based head office is also the home of our MHRA^*approved sterile injectable manufacturing facility, which has been established for over 60 years.

* Medicines and Healthcare Products Regulatory Agency

‹ ›

Introduction
What we do
Vision, mission & values
Our UK location

Product catalogue

Excludes Private Label

View all products >

News & Events

Wockhardt UK’s Amoxicillin Sodium 250mg, 500mg and 1g Powder for Solution for Injection

Based on MHRA's review of available data, the Commission on Human Medicines' Paediatric Medicine Expert Advisory Group (PMEAG) has advised that Wockhardt UK's Amoxicillin Sodium Powder for Solution for Injection can be used with caution in neonates and infants

Our Latest News & Events >

News & Events

Wockhardt announces COVID-19 vaccine partnership with UK Government

3rd August 2020, PRESS RELEASE

Wockhardt announces COVID-19 vaccine partnership with UK Government

Wockhardt, the global pharmaceutical and biotechnology major today announced that it has entered into an agreement with the UK Government to fill finish COVID-19 vaccines. The manufacturing will be undertaken at CP Pharmaceuticals, a subsidiary of Wockhardt based in Wrexham, North Wales.

As per the terms of the agreement the company has reserved manufacturing capacity to allow for the supply of multiple vaccines to the UK Government in its fight against COVID-19, including AZD1222, the vaccine co-invented by the University of Oxford and its spin-out company, Vaccitech, and licensed by AstraZeneca.

Our Products

Wockhardt UK specialises in the manufacture and supply of generic and branded medicines, with a constantly growing portfolio of over 250 product lines.

Our products cover many therapy areas including anticoagulation, pain management, anti-infectives, diabetes and antibiotics. They are available in a wide range of preparations, ranging from tablets, capsules and injections, through to liquid medicines, ointments and creams.